• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020

tetano

Editor, Senior Moderator
PLoS One


. 2021 Jul 14;16(7):e0254667.
doi: 10.1371/journal.pone.0254667. eCollection 2021.
Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020


Greg Davis[SUP] 1 [/SUP], Allen J York[SUP] 1 [/SUP], Willis Clark Bacon[SUP] 1 [/SUP], Suh-Chin Lin[SUP] 1 [/SUP], Monica Malone McNeal[SUP] 1 [/SUP], Alexander E Yarawsky[SUP] 1 [/SUP], Joseph J Maciag[SUP] 1 [/SUP], Jeanette L C Miller[SUP] 1 [/SUP], Kathryn C S Locker[SUP] 1 [/SUP], Michelle Bailey[SUP] 2 [/SUP], Rebecca Stone[SUP] 2 [/SUP], Michael Hall[SUP] 2 [/SUP], Judith Gonzalez[SUP] 2 [/SUP], Alyssa Sproles[SUP] 1 [/SUP], E Steve Woodle[SUP] 3 [/SUP], Kristen Safier[SUP] 1 [/SUP], Kristine A Justus[SUP] 1 [/SUP], Paul Spearman[SUP] 1 [/SUP], Russell E Ware[SUP] 1 [/SUP], Jose A Cancelas[SUP] 2 [/SUP], Michael B Jordan[SUP] 1 [/SUP], Andrew B Herr[SUP] 1 [/SUP], David A Hildeman[SUP] 1 [/SUP], Jeffery D Molkentin[SUP] 1 [/SUP]



Affiliations

Abstract

The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA β-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein showed an overall prevalence of 8.40%, measured as 7.56% in the first 58 days and 9.24% in the last 58 days, and 12.86% in December 2020, which we extrapolated to ~20% as of March, 2021. Males and females showed similar rates of past infection, and rates among Hispanic or Latinos, African Americans and Whites were also investigated. Donors under 30 years of age had the highest rates of past infection, while those over 60 had the lowest. Geographic analysis showed higher rates of infectivity on the West side of Cincinnati compared with the East side (split by I-75) and the lowest rates in the adjoining region of Kentucky (across the Ohio river). These results in regional seroprevalence will help inform efforts to best achieve herd immunity in conjunction with the national vaccination campaign.
 
Back
Top Bottom